HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by LaCount, M. W. Articles by Lebioda, L. Search for Related Content PubMed PubMed Citation Articles by LaCount, M. W. Articles by Lebioda, L. Social Bookmarking                      What's this?

J Biol Chem, Vol. 273, Issue 46, 30406-30409, November 13, 1998

Structural Origins of L(+)-Tartrate Inhibition of Human Prostatic Acid Phosphatase

From the Department of Chemistry and Biochemistry, University of South Carolina, Columbia, South Carolina 29208

Acid phosphatase activity in the blood serum is usually separated into tartrate-resistant and tartrate-refractory, which is reported as the prostatic acid phosphatase level. Human prostatic acid phosphatase crystals soaked in N-propyl-L-tartramate were used to collect x-ray diffraction data to 2.9 Å resolution under cryogenic conditions. Positive difference electron density, corresponding to the inhibitor, was found. The quality of the electron density maps clearly shows the orientation of the carboxylate and N-propyl-substituted amide groups. The hydroxyl group attached to C3 forms two crucial hydrogen bonds with Arg-79 and His-257. Previous crystallographic studies compiled on the tartrate-rat prostatic acid phosphatase binary complex (Lindqvist, Y., Schneider, G., and Vihko, P. (1993) J. Biol. Chem. 268, 20744-20746) erroneously positioned D-tartrate into the active site. Modeling studies have shown that the C3 hydroxyl group on the D()-stereoisomer of tartrate, which does not significantly inhibit prostatic acid phosphatase, does not form strong hydrogen bonds with Arg-79 or His-257. The structure of human prostatic acid phosphatase, noncovalently bound in N-propyl-L-tartramate, is used to develop inhibitors with higher specificity and potency than L(+)-tartrate.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				Y. Wang, Z. Wei, Q. Bian, Z. Cheng, M. Wan, L. Liu, and W. Gong Crystal Structure of Human Bisphosphoglycerate Mutase J. Biol. Chem., September 10, 2004; 279(37): 39132 - 39138. [Abstract] [Full Text] [PDF]

				A. M. Shakarian, M. B. Joshi, E. Ghedin, and D. M. Dwyer Molecular Dissection of the Functional Domains of a Unique, Tartrate-resistant, Surface Membrane Acid Phosphatase in the Primitive Human Pathogen Leishmania donovani J. Biol. Chem., May 10, 2002; 277(20): 17994 - 18001. [Abstract] [Full Text] [PDF]

				X.-Q. Zhang, M.-S. Lee, S. Zelivianski, and M.-F. Lin Characterization of a Prostate-specific Tyrosine Phosphatase by Mutagenesis and Expression in Human Prostate Cancer Cells J. Biol. Chem., January 19, 2001; 276(4): 2544 - 2550. [Abstract] [Full Text] [PDF]